Roche Holding AG (OTCMKTS:RHHBY) Stake Cut by Hemenway Trust Co LLC

Hemenway Trust Co LLC lessened its holdings in Roche Holding AG (OTCMKTS:RHHBY) by 16.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,856 shares of the company’s stock after selling 1,150 shares during the quarter. Hemenway Trust Co LLC’s holdings in Roche were worth $234,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. AlphaMark Advisors LLC acquired a new position in Roche during the 3rd quarter valued at approximately $149,000. GAMMA Investing LLC lifted its stake in Roche by 61.5% in the second quarter. GAMMA Investing LLC now owns 5,038 shares of the company’s stock valued at $175,000 after buying an additional 1,919 shares during the last quarter. Archer Investment Corp boosted its holdings in shares of Roche by 10.6% during the second quarter. Archer Investment Corp now owns 6,810 shares of the company’s stock valued at $236,000 after acquiring an additional 652 shares during the period. Verity Asset Management Inc. acquired a new position in shares of Roche during the third quarter valued at $253,000. Finally, Waldron Private Wealth LLC bought a new position in shares of Roche during the second quarter worth about $263,000.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on RHHBY shares. Bank of America raised shares of Roche from a “neutral” rating to a “buy” rating in a research note on Friday, September 13th. Deutsche Bank Aktiengesellschaft downgraded Roche from a “hold” rating to a “sell” rating in a research report on Friday, September 13th. Three analysts have rated the stock with a sell rating, one has assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Roche Trading Up 0.0 %

Shares of Roche stock traded up $0.01 on Tuesday, hitting $37.62. The company had a trading volume of 1,125,788 shares, compared to its average volume of 2,109,059. Roche Holding AG has a 52 week low of $29.20 and a 52 week high of $42.43. The business has a 50-day simple moving average of $39.28 and a 200-day simple moving average of $36.99.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.